Print Page   |   Sign In   |   Register
Companies: Fortress Biotech, Inc. (FBIO)

Company Profile

Description

Fortress Biotech, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. Its product includes CNDO-109, a lysate that activates donor natural killer cells for the treatment of cancer-related and other conditions. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was founded in 2006 and is based in New York, New York.

Company Officers/Contacts

Dr. Lindsay Allan Rosenwald M.D. - Chairman, Chief Exec. Officer and Pres
Dr. Eric K. Rowinsky M.D. - Vice Chairman, Consultant and Member of Strategic Transaction Committee
Dr. Lucy Lu M.D. - Chief Financial Officer and Exec. VP
Dr. George C. Avgerinos Ph.D. - Sr. VP of Biologics Operations
Mr. Michael S. Weiss Esq. - Exec. Vice Chairman of Strategic Devel. and Director

Contact Information

23 Columbus Circle
15th Floor
New York, NY 10019

Financial Reporting/Disclosure

Reporting Status U.S. Reporting: SEC Reporting
Latest Report Mar 31, 2016 10-Q
CIK 0001429260
Fiscal Year End 12/31
OTC Marketplace Not Available

Profile Data

SIC - Industry Classification Not Available
Business Status Development Stage Company a/o Sep 30, 2011
Incorporated In: DE, USA
Year of Inc. 2006
Employees 12 a/o Sep 30, 2011

Company Notes

  • Formerly=Coronado Biosciences, Inc. until 4-2015

Service Providers

Accounting/Auditing Firm
PricewaterhouseCoopers
300 Madison Avenue
24th Floor
New York, NY, 10017
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

 

Community Search
Sign In